141 related articles for article (PubMed ID: 11337165)
21. Skin permeation of testosterone and its ester derivatives in rats.
Kim MK; Lee CH; Kim DD
J Pharm Pharmacol; 2000 Apr; 52(4):369-75. PubMed ID: 10813545
[TBL] [Abstract][Full Text] [Related]
22. Transdermal permeation enhancement of N-trimethyl chitosan for testosterone.
He W; Guo X; Zhang M
Int J Pharm; 2008 May; 356(1-2):82-7. PubMed ID: 18337030
[TBL] [Abstract][Full Text] [Related]
23. Formulation and in vivo evaluation of membrane-moderated transdermal therapeutic systems of nicardipine hydrochloride using carvone as a penetration enhancer.
Krishnaiah YS; Satyanarayana V; Bhaskar P
Drug Deliv; 2003; 10(2):101-9. PubMed ID: 12746056
[TBL] [Abstract][Full Text] [Related]
24. Enhanced local anesthetic action of mepivacaine from the bioadhesive gels.
Cho CW; Choi JS; Shin SC
Pak J Pharm Sci; 2011 Jan; 24(1):87-93. PubMed ID: 21190925
[TBL] [Abstract][Full Text] [Related]
25. The effect of permeation enhancers on the viscosity and the release profile of transdermal hydroxypropyl methylcellulose gel formulations containing diltiazem HCl.
Karakatsani M; Dedhiya M; Plakogiannis FM
Drug Dev Ind Pharm; 2010 Oct; 36(10):1195-206. PubMed ID: 20545504
[TBL] [Abstract][Full Text] [Related]
26. Improvement in bioavailability of transdermally applied flurbiprofen using tulsi (Ocimum sanctum) and turpentine oil.
Charoo NA; Shamsher AA; Kohli K; Pillai K; Rahman Z
Colloids Surf B Biointerfaces; 2008 Sep; 65(2):300-7. PubMed ID: 18579348
[TBL] [Abstract][Full Text] [Related]
27. Synergistic enhancement of testosterone transdermal delivery.
Nicolazzo JA; Morgan TM; Reed BL; Finnin BC
J Control Release; 2005 Apr; 103(3):577-85. PubMed ID: 15820405
[TBL] [Abstract][Full Text] [Related]
28. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers.
Krishnaiah YS; Satyanarayana V; Bhaskar P
Int J Pharm; 2002 Oct; 247(1-2):91-102. PubMed ID: 12429488
[TBL] [Abstract][Full Text] [Related]
29. Development of the ambroxol gels for enhanced transdermal delivery.
Cho CW; Choi JS; Shin SC
Drug Dev Ind Pharm; 2008 Mar; 34(3):330-5. PubMed ID: 18363149
[TBL] [Abstract][Full Text] [Related]
30. Enhanced transdermal delivery of pranoprofen from the bioadhesive gels.
Shin SC; Cho CW
Arch Pharm Res; 2006 Oct; 29(10):928-33. PubMed ID: 17121190
[TBL] [Abstract][Full Text] [Related]
31. Development of carvedilol transdermal patches: evaluation of physicochemical, ex vivo and mechanical properties.
Gannu R; Vishnu YV; Kishan V; Rao YM
PDA J Pharm Sci Technol; 2008; 62(6):391-401. PubMed ID: 19634343
[TBL] [Abstract][Full Text] [Related]
32. Design and evaluation of a monolithic drug-in-adhesive patch for testosterone based on styrene-isoprene-styrene block copolymer.
Ma J; Wang C; Luo H; Zhu Z; Wu Y; Wang H
J Pharm Sci; 2013 Jul; 102(7):2221-34. PubMed ID: 23650152
[TBL] [Abstract][Full Text] [Related]
33. Bioavailability of nerodilol-based transdermal therapeutic system of nicorandil in human volunteers.
Krishnaiah YS; Al-Saidan SM; Chandrasekhar DV; Satyanarayana V
J Control Release; 2005 Aug; 106(1-2):111-22. PubMed ID: 15993975
[TBL] [Abstract][Full Text] [Related]
34. Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies.
Fang JY; Sung KC; Lin HH; Fang CL
Int J Pharm; 1999 Feb; 178(1):83-92. PubMed ID: 10205628
[TBL] [Abstract][Full Text] [Related]
35. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
Cho CW; Choi JS; Yang KH; Shin SC
Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
[TBL] [Abstract][Full Text] [Related]
36. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
[TBL] [Abstract][Full Text] [Related]
37. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
Akram M; Naqvi SB; Khan A
Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
[TBL] [Abstract][Full Text] [Related]
38. Effects of vehicles and enhancers on transdermal delivery of clebopride.
Rhee YS; Huh JY; Park CW; Nam TY; Yoon KR; Chi SC; Park ES
Arch Pharm Res; 2007 Sep; 30(9):1155-61. PubMed ID: 17958335
[TBL] [Abstract][Full Text] [Related]
39. Influence of menthol and pressure-sensitive adhesives on the in vivo performance of membrane-moderated transdermal therapeutic system of nicardipine hydrochloride in human volunteers.
Krishnaiah YS; Satyanarayana V; Bhaskar P
Eur J Pharm Biopharm; 2003 May; 55(3):329-37. PubMed ID: 12754008
[TBL] [Abstract][Full Text] [Related]
40. Formulation and evaluation of a testosterone transdermal spray.
Leichtnam ML; Rolland H; Wüthrich P; Guy RH
J Pharm Sci; 2006 Aug; 95(8):1693-702. PubMed ID: 16795012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
